Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

304 trials with published results (34%)

Research Maturity

572 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

2.0%

18 terminated out of 899 trials

Success Rate

96.9%

+10.4% vs benchmark

Late-Stage Pipeline

8%

76 trials in Phase 3/4

Results Transparency

53%

304 of 572 completed with results

Key Signals

304 with results97% success18 terminated

Data Visualizations

Phase Distribution

741Total
Not Applicable (623)
Early P 1 (3)
P 1 (22)
P 2 (17)
P 3 (36)
P 4 (40)

Trial Status

Completed572
Unknown105
Recruiting79
Active Not Recruiting51
Not Yet Recruiting45
Withdrawn18

Trial Success Rate

96.9%

Benchmark: 86.5%

Based on 572 completed trials

Clinical Trials (899)

Showing 20 of 20 trials
NCT07533149Not ApplicableNot Yet Recruiting

Targeted Lens Intervention for Myopic Anisometropia in Children

NCT07276347Not ApplicableCompleted

Comprehensive Assessment of Multiple Products (CAMP)

NCT07522242Phase 2RecruitingPrimary

Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression

NCT06758076Not ApplicableCompleted

A Clinical Comparison of Two Soft Contact Lenses (C24-755)

NCT06869044Not ApplicableCompletedPrimary

A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add

NCT07511387Not ApplicableNot Yet RecruitingPrimary

Efficacy of a Novel Myopia Defocus Spectacle Lens in School-Aged Children

NCT06873048Not ApplicableCompleted

Short-term Study of Two Soft Contact Lenses in Wearers With Low Astigmatism

NCT06817785Not ApplicableCompletedPrimary

Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere

NCT07104773Not ApplicableCompleted

Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses

NCT01638390Phase 1CompletedPrimary

Use of the VisuMax™ Femtosecond Laser

NCT07505264Not ApplicableRecruitingPrimary

Comparison of Myopic Small Incision Lenticule Extraction (SMILE) With VISUMAX 500 Versus VISUMAX 800 Platforms

NCT06668909CompletedPrimary

Patient Reported Outcomes With WaveLight LASIK

NCT06278974RecruitingPrimary

Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K

NCT05886348Not ApplicableActive Not RecruitingPrimary

The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens

NCT06577948Not ApplicableActive Not RecruitingPrimary

The P.A.U.S.E.® Spectacle Study

NCT07129798Not ApplicableActive Not Recruiting

Efficacy and Safety of Myopic Macular Hole Closure Surgery Without Endotamponade Agent

NCT05856786Recruiting

To Study the Effects of Refractive Surgery on OCT Measurements in the Eye

NCT07478419CompletedPrimary

Machine Learning Prediction of 1-Year Refractive Error After SMILE

NCT04283149Not ApplicableCompletedPrimary

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

NCT07475585Not ApplicableNot Yet RecruitingPrimary

Effects of Auricular Point Pressing With Pellets in Children With Insufficient Hyperopia Reserve

Scroll to load more

Research Network

Activity Timeline